January 1, 1999Open Access
Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses.
Key Points
Key points are not available for this paper at this time.
Abstract
T he overall aim of the NHS R&D Health Technology Assessment (HTA) programme is to ensure that high-quality research information on the costs, effectiveness and broader impact of health technologies is produced in the most efficient way for those who use, manage and work in the NHS. Research is undertaken in those areas where the evidence will lead to the greatest benefits to patients, either through improved patient outcomes or the most efficient use of NHS resources.